Evaluation and management of pulmonary disease in ataxia-telangiectasia - Wikidata - awgldk - TriplyDB

Evaluation and management of pulmonary disease in ataxia-telangiectasia

Evaluation and management of pulmonary disease in ataxia-telangiectasia

http://www.wikidata.org/entity/Q34120793

about

Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor Ataxia telangiectasia: a review Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia.Pulmonary function in children and young adults with ataxia telangiectasia.Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.Ataxia telangiectasia: more variation at clinical and cellular levels.Ataxia-telangiectasia: recommendations for multidisciplinary treatment.Workshop report: European workshop on ataxia-telangiectasia, Frankfurt, 2011.Genetic Ataxia Telangiectasia porcine model phenocopies the multisystemic features of the human disease.Rapid and progressive pulmonary fibrosis in 2 families with DNA repair deficiencies of undetermined etiology.Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia.Assessment of impaired coordination between respiration and deglutition in children and young adults with ataxia telangiectasia.Infections of the respiratory system in patients with ataxia-telangiectasia.Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia.Ataxia telangiectasia syndrome: moonlighting ATM.Loss of ATM in Airway Epithelial Cells Is Associated with Susceptibility to Oxidative Stress.Effects of inspiratory muscle training on lung volumes, respiratory muscle strength, and quality of life in patients with ataxia telangiectasia.Anesthetic and perioperative risk in the patient with Ataxia-Telangiectasia.Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of ATM-competent cells.Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.Therapeutic targets and investigated treatments for Ataxia-Telangiectasia

P2860

Q21202872-54C0519C-E686-4F09-82BD-91F915EF0784 Q26777987-228DCA3E-4F81-4535-BF55-B432302D353F Q28079581-89D07CBB-2568-47F8-A4C4-3C188A641999 Q35177611-B3A10FC9-4D72-40C0-A342-75BC4D2DACB1 Q35581177-3CB6018E-4C2F-42B5-8800-F52C89248A2F Q36397423-70882538-5945-4D2F-8C5C-5309856AA906 Q38231497-2044DE2E-7AD2-4709-BCBF-4B57245DF8AA Q39187349-BC3AE87B-7BAC-4D6D-B3D2-3E4CA9DA67AB Q39731839-E9EAB7FD-041F-4D34-99FD-D653A842A4F1 Q40107367-DB172083-3415-4024-B7F7-C291B98AD082 Q40295578-F7337530-6037-4D5F-AD7C-BCA6867C4785 Q41456647-C348C201-4A9B-4F5D-BE2D-C7179FF2E876 Q41639966-EB06DFE4-5AB7-4255-AC8C-834E29B4F662 Q43753540-95631D3E-C0AD-4727-ACA9-DBC8332F81DB Q45805245-24539404-0AC9-42F8-A20A-358D73359A13 Q46254824-6D9CC7A4-560B-42A9-ACBA-1CE3CE8A571B Q47649609-7F8873E6-BC89-4780-B961-9DB79C37641F Q47973030-025820AD-BC4D-4CF8-9E85-6699E51D4895 Q48185635-D13BB564-5EE5-4930-A310-57DE4D7E46A1 Q48212680-F2A91D33-E73D-4973-A6BA-BC26CB49AEC8 Q48320051-B464D1D2-ED0B-42CD-8CEC-8E778728C25D Q50235468-B7F5F47F-9754-4728-B2AB-693C85A73E42 Q59198405-AEC8C447-5AE5-4349-A186-0766AD735456

P2860

Evaluation and management of pulmonary disease in ataxia-telangiectasia

http://www.wikidata.org/entity/Q34120793

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@ast

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@en

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@nl

type

label

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@ast

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@en

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@nl

prefLabel

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@ast

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@en

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@nl

P1433

Q34120793-A81E7652-BCC5-4EDE-B59E-2590E9BC7D43

P1476

Q34120793-F9EFD068-2CA0-458B-9AC2-78C98B6ED4AE

P2093

Q34120793-1254E1A7-D23F-44F5-97F2-B20863AA5309

Q34120793-1E1C4F32-A237-4447-89EB-B55AADD3ADCB

Q34120793-4421DD8E-C04A-4FD8-87B8-4B5F3D2D8E6A

Q34120793-55855F27-8603-4747-9A59-E3EBD52C88D8

Q34120793-55DE9FA9-960D-4669-888A-1F18F4CC17E0

Q34120793-5A8FCEDB-123C-4C98-A3E1-299A447EB7F5

Q34120793-6C96F40C-C987-4A03-B851-8DB3BC5E7A38

Q34120793-6E2F17E2-02A8-4A61-B82E-BF4560898A09

Q34120793-76201B37-5B03-4697-B945-57B1D9232C11

Q34120793-9507225F-5828-416D-8E53-6287D4F1959D

P2860

Q34120793-02858924-5FA3-4F77-AC35-675DC5FD29E6

Q34120793-07F38D7E-76A0-43DA-AF10-B46CAE3C2668

Q34120793-1AFAC303-7147-405E-9331-DCE63EE6FCF1

Q34120793-1B13C200-3E2F-4968-8268-1FEDE31CBFCC

Q34120793-1D2BE9B1-A9EB-49F5-BC1E-4E4F3A38E2FC

Q34120793-2436E74C-2E48-4554-9AC6-97C5CA29272A

Q34120793-25036504-F116-4DDC-BB7A-950AA34D2732

Q34120793-26AA995C-816C-47FC-8963-526781AFA6C2

Q34120793-2A71785D-C7C5-4F5E-AEF5-66C7D74F9E27

Q34120793-2AFCE1F7-16C0-4AB5-97EF-816130F8260D

P304

Q34120793-3A81E7CF-4016-4122-B0C8-A6EA13481E90

P31

Q34120793-7007AA31-E131-4237-92D3-2CDBB223E8A5

P356

Q34120793-3EDBFA10-09A6-4AEE-8BE6-F1FD134A1AE7

P433

Q34120793-E5E3E9E8-5882-4236-AF8A-6F3A3F03DA7B

P478

Q34120793-ACB96A83-07E1-4386-A76C-3C5E0354CF34

P50

Q34120793-4E659935-E911-49DE-8FD1-CE8E54D14DA2

Q34120793-E52A6B6F-67C9-4DB5-82B6-5A2852D681B7

P577

Q34120793-90D3765A-4F89-4B44-A433-34A21D52949F

P698

Q34120793-86ACB2A3-9DCD-41DC-B989-6FF20EED6058

P932

Q34120793-86DB7F33-ABEA-45C3-B6C5-9DA7F7584E96

P356

P1433

Pediatric Pulmonology

P1476

Evaluation and management of pulmonary disease in ataxia-telangiectasia

@en

P2093

Alan S Brody

http://www.w3.org/2001/XMLSchema#string

Blaine Easley

http://www.w3.org/2001/XMLSchema#string

Claire Langston

http://www.w3.org/2001/XMLSchema#string

Gerald M Loughlin

http://www.w3.org/2001/XMLSchema#string

Howard M Lederman

http://www.w3.org/2001/XMLSchema#string

John T Sandlund

http://www.w3.org/2001/XMLSchema#string

Leland L Fan

http://www.w3.org/2001/XMLSchema#string

Maureen A Lefton-Greif

http://www.w3.org/2001/XMLSchema#string

Michelle Troche

http://www.w3.org/2001/XMLSchema#string

Paul G Auwaerter

http://www.w3.org/2001/XMLSchema#string

P2860

A review of the evidence for the medical home for children with special health care needs

Assessment of ventilatory function in patients with neuromuscular disease.

Autosomal recessive cerebellar ataxias.

Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.

Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.

Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia.

Quantitative neurologic assessment of ataxia-telangiectasia.

Ataxia-telangiectasia: some historic, clinical and pathologic observations.

ATM and ataxia telangiectasia.

Immunodeficiency and infections in ataxia-telangiectasia.

P304

847-859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PPUL.21277

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Cynthia Rothblum-Oviatt

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20583220

http://www.w3.org/2001/XMLSchema#string

P932

4151879

http://www.w3.org/2001/XMLSchema#string